← All trials
NCT07047612
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 9, 2025
- Primary completion
- Apr 30, 2029
- Completion date
- Apr 30, 2029
- First posted
- Jul 2, 2025
- Last posted
- Aug 7, 2025
- Enrollment
- 603
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing InnoCare Pharma Tech Co., Ltd.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.